TIMH
GILD icon

Tilt Investment Management Holdings’s Gilead Sciences GILD Stock Holding History

Tilt Investment Management Holdings’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$411K Sell
5,072
-1,438
-22% -$112K 0.44% 58
2023
Q3 		$488K Hold
6,510
– – 0.35% 86
2023
Q2 		$502K Hold
6,510
– – 0.33% 89
2023
Q1 		$518K Buy
6,510
+849
+15% +$70.3K 0.38% 79
2022
Q4 		$486K Buy
+5,661
New +$448K 0.41% 78

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tilt Investment Management Holdings's GILD Position: Q4 2023 in Review

Tilt Investment Management Holdings reduced its Gilead Sciences (GILD) stake by 22% in Q4 2023, selling an estimated $112K and leaving 5,072 shares worth $411K. The position accounts for 0.44% of the portfolio, ranked #58.

Tilt Investment Management Holdings first reported a position in GILD in Q4 2022 and has held it in 5 quarters since. The position peaked at $518K in Q1 2023. 1,776 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

  • Tilt Investment Management Holdings held 5,072 shares of Gilead Sciences worth $411K as of Q4 2023.
  • Tilt Investment Management Holdings sold 1,438 Gilead Sciences shares in Q4 2023, an estimated $112K.
  • Gilead Sciences made up 0.44% of Tilt Investment Management Holdings's portfolio in Q4 2023, its #58 holding.
  • Tilt Investment Management Holdings first reported a position in Gilead Sciences in Q4 2022 and has held it in 5 quarters since.
  • Tilt Investment Management Holdings's Gilead Sciences position peaked at $518K in Q1 2023.
  • 1,776 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on Tilt Investment Management Holdings's 13F filing for Q4 2023, filed 31 Jan 2024.